Introduction: Carbapenems are considered to be the last choice for drug resistant Gram-negative bacteria but emergence of carbapenem resistant Gram-negative bacteria worldwide due to the production of carbapenemase has jeopardize their use. Aims and objectives:To detect the prevalence of carbapenem resistance in Gram-negative bacteria and carbapenemase production by Modified Hodge Test. Materials and Methods:A total of 160 isolates of Gram-negative bacteria from November 2012 to October 2014, from different clinical samples were included in the study. Those isolates with intermediate or resistant zone to meropenem and doripenem by disc diffusion methods according to CLSI guidelines were confirmed by E-test and were again tested for carbapenemase production by Modified Hodge Test (MHT). Results: Out of 160 isolates, 48 (30%) showed resistance to carbapenem by disc diffusion and E-test.Carbapenem resistance was higher in female patients 41.6% than in male patients 15.5% and among ICU patients 57.1%, ward patients 33.3% and among OPD patients 13.8%. Maximum number of carbapenem resistant isolate was obtained from urine sample n= 20, followed by pus n=13 and wound swab n=7. MHT for carbapenemase production was positive in 29 (60.4%) of the isolates. Carbapenemase production by MHT was highest with Acinetobacter spp. with n=5 (83.3%), followed by Pseudomonas spp. n= 6 (75%) and E.coli spp. n=16 (65.5%) and nil among Citrobacter spp. Conclusions:Carbapenem resistance due to production of carbapenemase is prevalent in our hospital. MHT is a simple test in the routine lab for detection of carbapenemases.
INTRODUCTIONPseudomonas aeruginosa is an aerobic, motile, nutritionally versatile, gram negative bacteria. It is ubiquitous, human opportunistic pathogen and has implications on morbidity, mortality and healthcare costs both in hospitals and in the community.1 Infections caused by P. aeruginosa are frequently life-threatening and difficult to treat causing increased stay in hospital and even increased morbidity and mortality as it exhibits intrinsically high resistance to many antimicrobials and the development of multi-drug resistance in health care settings.2,3 Biofilms are defined as microbially derived sessile communities characterized by the cells that are irreversibly attached to a substratum or to each other. They are embedded in a matrix of extracellular polymeric substances (EPS) they have produced, and exhibit an altered phenotype with respect to growth rate and gene transcription.4 Within a biofilm, bacteria communicate with each other by production of chemotactic particles or ABSTRACT Background: Pseudomonas aeruginosa is an ubiquitous pathogen capable of surviving in a variety of environmental conditions. It is increasingly gaining importance as a multidrug resistant nosocomial pathogen. Biofilm acts as a barrier, reducing the penetration of these drugs and consequently, preventing them from exercising their actions. The aim of this study is to isolate and identify Pseudomonas aeruginosa from various clinical specimen and to find out their production of biofilms and their correlation with antibiotic susceptibility pattern. Methods: All Pseudomonas aeruginosa over a period of 1 year were isolated and identified from clinical specimens and antibiotic susceptibility test was done following standard operative procedures. Biofilm detection was done by Congo Red Agar method (CRA). Results: 134 isolates of Pseudomonas aeruginosa was isolated. Maximum isolates were isolated from sputum samples 55 (41%) and most were from wards 68 (51%) giving a probability of increased healthcare associated infections. Biofilm production by the isolates was seen in 39 (29%). All the biofilm producing isolates shows more resistant pattern in comparison to non-biofilm producers. 69% of Imipenem and 82% of Meropenem resistant isolates produce biofilm. All the P. aeruginosa including MDR and biofilm forming strains were sensitive to Colistin. Conclusions: Resistance to antimicrobial agents is the most important feature of biofilm infections. Ability of P. aeruginosa to form biofilms renders antibiotic treatments inefficient and therefore promotes chronic infectious diseases. As a result, infections caused by bacterial biofilms are persistent and very difficult to eradicate.
Background: Acinetobacter is an important opportunistic pathogen and is a common cause of hospital acquired infections. Acinetobacter infections are often extremely difficult to treat because of their widespread resistance to the major groups of antibiotics. The study was conducted to determine prevalence and antibiotic susceptibility pattern of Acinetobacter species isolated from various clinical samples.Methods: Clinical specimens over a period of 2yrs from May 2015 to April 2017 were collected from the patients attending the hospital. Acinetobacter species isolates were identified, and antibiotic susceptibility test was done following standard operative procedures.Results: From 9979 clinical specimens, 3715 were positive for significant bacterial growth of which 111 (2.9%) were culture positive for Acinetobacter spp. Among 111 isolates 109 (98.2%) isolates were Acinetobacter baumanni and 2 (1.8%) were Acinetobacter lwoffii. Maximum isolates were isolated from urine samples 36 (32.4%) and majority of the isolates were from wards (56.7%) giving a probability of increased hospital acquired infections. Maximum resistance was shown by cefipime (80.1%). Imipenem and Meropenem shows resistance of 25.3% and 29.7% respectively. ICU isolates showed extensive resistance in comparison to wards and OPD.Conclusions: Increasing trend of resistance pattern to a large range of antibiotics is a matter of concern. To avoid resistance, antibiotics should be used judiciously, and empirical therapy should be determined for each hospital according to the resistance rates of the hospital. Infection with MDR Acinetobacter species is independently associated with high mortality, emphasizing the need for aggressive infection control strategies.
Background: Diarrhoeal diseases are responsible for causing 3 million deaths worldwide every year especially among the children and also the commonest cause of morbidity and mortality in developing countries like India. Infective diarrhoea could be either bacterial, viral, parasitic or occasionally a combination of these.Methods: A cross-sectional study was carried out in children below 12 years with acute diarrhoea in theMicrobiology Department, RIMS, Imphal for a period of 2 years. Stool samples were subjected to routine microbiological examination, followed by culture and sensitivity. Data were collected in a predesigned data collection sheet.Results: Majority of the diarrhoeal cases were seen among the age group of 1-3 years (44.3%), predominantly among the male children (66.2%) and mostly in summer. Out of 210 culture positive stool samples, Escherichia coli(83.3%) was the predominant enteropathogen with followed by Shigella spp.(12.9%), Klebsiella spp. (2.9%) and Salmonella spp. (1%). Serotyping revealed thirty five enteropathogenic E. coli, eighteen Shigella flexneri, seven Shigellasonnei, two Shigella boydii and two Salmonella typhimurium. Majority of the isolates showed high resistance to amoxicillin, ampicillin, ciprofloxacin, ofloxacin and cotrimoxazole.Conclusions: Bacterial enteropathogens are an important cause of acute diarrhoea among children. Rehydration therapy remains the initial treatment. Though it is usually self-limiting, empirical and specific antimicrobial therapy can be considered in certain situations. Awareness of improving hygiene and infectious diseases may help reduce the burden of infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.